APP and amyloidosis: Because the degree of APP overexpression – along with the mutations expressed – govern the amount and form of Aβ produced and therefore dictate the rate of amyloid deposition, many of these models use transgene promoters chosen for their ability to produce stable and high expression levels throughout the adult brain (Jankowsky and Zheng, 2017).